Volkan Korten

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanrıöver, Levent Doğanay, Murat Akova et al. · The Lancet · 2021 · 929 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Crimean-Congo Hemorrhagic Fever in Turkey

S. Sami Kartı, Zekaver Odabaşı, Volkan Korten et al. · Emerging infectious diseases · 2004 · 307 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide-Resistant Enterococci

P Van der Auwera, N. Pensart, Volkan Korten et al. · The Journal of Infectious Diseases · 1996 · 237 citations · Full text

Life Sciences, Microbiology, Antimicrobial Pharmacology +12

Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

Andrea Antinori, Gabriele Arendt, Igor Grant et al. · Clinical Infectious Diseases · 2012 · 208 citations · Full text

Medicine, Neurology, Cognitive Neurology +15

Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy

Alain Cometta, Winfried V. Kern, R. De Bock et al. · Clinical Infectious Diseases · 2003 · 168 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17